Koywe vs ArkeaBio

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (26 vs 30)
Koywe logo

Koywe

EmergingFinance

General

Uruguay YC W23 compliant crypto on/off-ramp APIs for Latin America in Chile/Mexico/Colombia/Peru; $1.6M Manutara/Daedalus seed, acquired FACTO Jun 2024, joined Borderless May 2025, 5x MoM growth competing with Bitso for LatAm stablecoin payment infrastructure.

AI VisibilityBeta
Overall Score
D26
Category Rank
#389 of 1158
AI Consensus
61%
Trend
up
Per Platform
ChatGPT
24
Perplexity
32
Gemini
22

About

Koywe is a Montevideo, Uruguay-based crypto payment infrastructure company — backed by Y Combinator (W23) with $1.6 million in total funding including a $1.1 million seed in January 2023 led by Manutara Ventures with Daedalus Ventures, Bridge Latam, and Rhombuz — providing fintech companies, payment processors, and digital wallets across Latin America with fully compliant crypto on-ramp and off-ramp APIs and SDKs that enable stablecoin settlement in local currency within minutes. Operating in Chile, Mexico, Colombia, and Peru with 12 employees, Koywe acquired FACTO in June 2024 and joined the Borderless network in May 2025, achieving 5x month-over-month growth to become one of the leading LatAm compliant crypto payment rails for remittances, USD wallet funding, and foreign exchange products.

Full profile
ArkeaBio logo

ArkeaBio

EmergingAgTech

Livestock Biotech (Methane Reduction)

$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.

AI VisibilityBeta
Overall Score
D30
Category Rank
#1 of 1
AI Consensus
66%
Trend
up
Per Platform
ChatGPT
36
Perplexity
28
Gemini
29

About

ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.

Full profile

AI Visibility Head-to-Head

26
Overall Score
30
#389
Category Rank
#1
61
AI Consensus
66
up
Trend
up
24
ChatGPT
36
32
Perplexity
28
22
Gemini
29
33
Claude
40
18
Grok
39

Key Details

Category
General
Livestock Biotech (Methane Reduction)
Tier
Emerging
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only ArkeaBio
Livestock Biotech (Methane Reduction)

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.